MFS
AXSM icon

Mirabella Financial Services’s Axsome Therapeutics AXSM Stock Holding History

Mirabella Financial Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Buy
+1,367
New +$296K 0.03% 406
2023
Q1 		– Sell
-3,311
Closed -$255K – 401
2022
Q4 		$255K Buy
+3,311
New +$198K 0.02% 277

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mirabella Financial Services's AXSM Position: Q2 2026 in Review

Mirabella Financial Services opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 1,367 shares worth $335K. The stake represents 0.03% of the portfolio and ranks #406 among its holdings. This is a return to the name: Mirabella Financial Services previously reported a position in AXSM as recently as Q4 2022.

Mirabella Financial Services first reported a position in AXSM in Q4 2022 and has held it in 2 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Mirabella Financial Services held 1,367 shares of Axsome Therapeutics worth $335K as of Q2 2026.
  • Axsome Therapeutics was a new Mirabella Financial Services position in Q2 2026.
  • Axsome Therapeutics made up 0.03% of Mirabella Financial Services's portfolio in Q2 2026, its #406 holding.
  • Mirabella Financial Services first reported a position in Axsome Therapeutics in Q4 2022 and has held it in 2 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.